FHA
IONS icon

First Horizon Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

First Horizon Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-112
Closed -$3.38K – 2417
2025
Q1 		$3.38K Hold
112
– – ﹤0.01% 1885
2024
Q4 		$3.92K Hold
112
– – ﹤0.01% 1852
2024
Q3 		$4.49K Buy
+112
New +$5.21K ﹤0.01% 1829
2020
Q1 		– Sell
-35
Closed -$2K – 1469
2019
Q4 		$2K Hold
35
– – ﹤0.01% 1383
2019
Q3 		$2K Hold
35
– – ﹤0.01% 1382
2019
Q2 		$2K Buy
35
+7
+25% +$495 ﹤0.01% 1389
2019
Q1 		$2K Hold
28
– – ﹤0.01% 1409
2018
Q4 		$1K Hold
28
– – ﹤0.01% 1441
2018
Q3 		$1K Sell
28
-680
-96% -$31.9K ﹤0.01% 1477
2018
Q2 		$29K Hold
708
– – ﹤0.01% 763
2018
Q1 		$30K Hold
708
– – ﹤0.01% 658
2017
Q4 		$37K Sell
708
-218
-24% -$12K ﹤0.01% 606
2017
Q3 		$48K Hold
926
– – ﹤0.01% 510
2017
Q2 		$44K Sell
926
-162
-15% -$7.54K ﹤0.01% 519
2017
Q1 		$51K Sell
1,088
-98
-8% -$4.4K 0.01% 518
2016
Q4 		$32K Hold
1,186
– – ﹤0.01% 660
2016
Q3 		$32K Sell
1,186
-261
-18% -$8.17K ﹤0.01% 654
2016
Q2 		$33K Buy
1,447
+115
+9% +$3.71K ﹤0.01% 619
2016
Q1 		$45K Buy
1,332
+541
+68% +$22K 0.01% 567
2015
Q4 		$48K Sell
791
-123
-13% -$6.64K 0.01% 500
2015
Q3 		$36K Buy
914
+8
+0.9% +$414 0.01% 613
2015
Q2 		$52K Buy
906
+85
+10% +$5.4K 0.01% 539
2015
Q1 		$53K Buy
821
+59
+8% +$4K 0.01% 538
2014
Q4 		$47K Buy
762
+28
+4% +$1.38K 0.01% 560
2014
Q3 		$28K Buy
734
+47
+7% +$1.67K ﹤0.01% 705
2014
Q2 		$21K Buy
687
+114
+20% +$3.59K ﹤0.01% 813
2014
Q1 		$22K Hold
573
– – ﹤0.01% 740
2013
Q4 		$26K Buy
573
+512
+839% +$18.2K ﹤0.01% 651
2013
Q3 		$2K Buy
+61
New +$1.82K ﹤0.01% 1072

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

First Horizon Advisors's IONS Position: Q2 2025 in Review

First Horizon Advisors sold out of Ionis Pharmaceuticals (IONS) in Q2 2025, closing a stake of 112 shares — an estimated $3.38K sold.

First Horizon Advisors first reported a position in IONS in Q3 2013 and held it in 29 quarters. The position peaked at $53K in Q1 2015. 363 funds tracked by Wall St. Rank hold IONS as of Q2 2025.

  • First Horizon Advisors reported no remaining Ionis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • First Horizon Advisors sold 112 Ionis Pharmaceuticals shares in Q2 2025, an estimated $3.38K.
  • First Horizon Advisors first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 29 quarters.
  • First Horizon Advisors's Ionis Pharmaceuticals position peaked at $53K in Q1 2015.
  • 363 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.